Editorials

Europe's health research: getting the right balance

BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7134.795 (Published 14 March 1998) Cite this as: BMJ 1998;316:795

Preoccupation with technology mustn't erode public health research

  1. Rodolfo Saracci, Director of research in epidemiology,
  2. Jørn Olsen, Professor,
  3. Anthony McMichael, Professor of epidemiology
  1. Institute of Clinical Physiology, National Research Council, 56126 Pisa, Italy
  2. Danish Epidemiology Science Centre, University of Aarhus, DK-8000, Aarhus C, Denmark
  3. London School of Hygiene and Tropical Medicine, London WC1 7HT

    Negotiations on the European Union's fifth framework programme of research are at a critical juncture. Within the next few weeks discussions between the council of ministers and the European parliament will determine the direction of collaborative multinational research in Europe over the next five years. Funds for the life sciences programme, which includes health, are likely to amount to 2-2.5 billion ecu. The programme will be based on “key actions” proposed by the European Commission. These currently include food and health, vaccines, health and the environment, biotechnology, and aging.1 How funds will be apportioned is yet to be decided, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe